151 related articles for article (PubMed ID: 21925481)
21. A High-Throughput Mass Spectrometry Assay Coupled with Redox Activity Testing Reduces Artifacts and False Positives in Lysine Demethylase Screening.
Wigle TJ; Swinger KK; Campbell JE; Scholle MD; Sherrill J; Admirand EA; Boriack-Sjodin PA; Kuntz KW; Chesworth R; Moyer MP; Scott MP; Copeland RA
J Biomol Screen; 2015 Jul; 20(6):810-20. PubMed ID: 25755264
[TBL] [Abstract][Full Text] [Related]
22. Structural and functional analysis of JMJD2D reveals molecular basis for site-specific demethylation among JMJD2 demethylases.
Krishnan S; Trievel RC
Structure; 2013 Jan; 21(1):98-108. PubMed ID: 23219879
[TBL] [Abstract][Full Text] [Related]
23. Inhibitors of Jumonji C domain-containing histone lysine demethylases overcome cisplatin and paclitaxel resistance in non-small cell lung cancer through APC/Cdh1-dependent degradation of CtIP and PAF15.
Duan L; Perez RE; Calhoun S; Maki CG
Cancer Biol Ther; 2022 Dec; 23(1):65-75. PubMed ID: 35100078
[TBL] [Abstract][Full Text] [Related]
24. Reconstitution of nucleosome demethylation and catalytic properties of a Jumonji histone demethylase.
Shiau C; Trnka MJ; Bozicevic A; Ortiz Torres I; Al-Sady B; Burlingame AL; Narlikar GJ; Fujimori DG
Chem Biol; 2013 Apr; 20(4):494-9. PubMed ID: 23601638
[TBL] [Abstract][Full Text] [Related]
25. Human histone demethylase KDM6B can catalyse sequential oxidations.
Hopkinson RJ; Langley GW; Belle R; Walport LJ; Dunne K; Münzel M; Salah E; Kawamura A; Claridge TDW; Schofield CJ
Chem Commun (Camb); 2018 Jul; 54(57):7975-7978. PubMed ID: 29961803
[TBL] [Abstract][Full Text] [Related]
26. The Cross Marks the Spot: The Emerging Role of JmjC Domain-Containing Proteins in Myeloid Malignancies.
Staehle HF; Pahl HL; Jutzi JS
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944554
[TBL] [Abstract][Full Text] [Related]
27. Insights into The Function and Regulation of Jumonji C Lysine Demethylases as Hypoxic Responsive Enzymes.
Chopra A; Adhikary H; Willmore WG; Biggar KK
Curr Protein Pept Sci; 2020; 21(7):642-654. PubMed ID: 31889485
[TBL] [Abstract][Full Text] [Related]
28. Emerging Roles of JmjC Domain-Containing Proteins.
Accari SL; Fisher PR
Int Rev Cell Mol Biol; 2015; 319():165-220. PubMed ID: 26404469
[TBL] [Abstract][Full Text] [Related]
29. Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer.
Liu H; Liu L; Holowatyj A; Jiang Y; Yang ZQ
Mol Carcinog; 2016 May; 55(5):977-90. PubMed ID: 26207617
[TBL] [Abstract][Full Text] [Related]
30. Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor.
Kristensen LH; Nielsen AL; Helgstrand C; Lees M; Cloos P; Kastrup JS; Helin K; Olsen L; Gajhede M
FEBS J; 2012 Jun; 279(11):1905-14. PubMed ID: 22420752
[TBL] [Abstract][Full Text] [Related]
31. Histone demethylation by a family of JmjC domain-containing proteins.
Tsukada Y; Fang J; Erdjument-Bromage H; Warren ME; Borchers CH; Tempst P; Zhang Y
Nature; 2006 Feb; 439(7078):811-6. PubMed ID: 16362057
[TBL] [Abstract][Full Text] [Related]
32. The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases.
Roatsch M; Hoffmann I; Abboud MI; Hancock RL; Tarhonskaya H; Hsu KF; Wilkins SE; Yeh TL; Lippl K; Serrer K; Moneke I; Ahrens TD; Robaa D; Wenzler S; Barthes NPF; Franz H; Sippl W; Lassmann S; Diederichs S; Schleicher E; Schofield CJ; Kawamura A; Schüle R; Jung M
ACS Chem Biol; 2019 Aug; 14(8):1737-1750. PubMed ID: 31287655
[TBL] [Abstract][Full Text] [Related]
33. Taking Me away: the function of phosphorylation on histone lysine demethylases.
Karakatsanis NM; Hamey JJ; Wilkins MR
Trends Biochem Sci; 2024 Mar; 49(3):257-276. PubMed ID: 38233282
[TBL] [Abstract][Full Text] [Related]
34. What Is the Catalytic Mechanism of Enzymatic Histone N-Methyl Arginine Demethylation and Can It Be Influenced by an External Electric Field?
Ramanan R; Waheed SO; Schofield CJ; Christov CZ
Chemistry; 2021 Aug; 27(46):11827-11836. PubMed ID: 33989435
[TBL] [Abstract][Full Text] [Related]
35. Dissecting contributions of catalytic and reader domains in regulation of histone demethylation.
Petronikolou N; Longbotham JE; Fujimori DG
Methods Enzymol; 2020; 639():217-236. PubMed ID: 32475402
[TBL] [Abstract][Full Text] [Related]
36. Is JmjC oxygenase catalysis limited to demethylation?
Hopkinson RJ; Walport LJ; Münzel M; Rose NR; Smart TJ; Kawamura A; Claridge TD; Schofield CJ
Angew Chem Int Ed Engl; 2013 Jul; 52(30):7709-13. PubMed ID: 23788451
[TBL] [Abstract][Full Text] [Related]
37. Structure-function relationships of human JmjC oxygenases-demethylases versus hydroxylases.
Markolovic S; Leissing TM; Chowdhury R; Wilkins SE; Lu X; Schofield CJ
Curr Opin Struct Biol; 2016 Dec; 41():62-72. PubMed ID: 27309310
[TBL] [Abstract][Full Text] [Related]
38. Enabling lead discovery for histone lysine demethylases by high-throughput RapidFire mass spectrometry.
Hutchinson SE; Leveridge MV; Heathcote ML; Francis P; Williams L; Gee M; Munoz-Muriedas J; Leavens B; Shillings A; Jones E; Homes P; Baddeley S; Chung CW; Bridges A; Argyrou A
J Biomol Screen; 2012 Jan; 17(1):39-48. PubMed ID: 21859681
[TBL] [Abstract][Full Text] [Related]
39. Insights into a Cancer-Target Demethylase: Substrate Prediction through Systematic Specificity Analysis for KDM3A.
Chopra A; Willmore WG; Biggar KK
Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625569
[TBL] [Abstract][Full Text] [Related]
40. Jumonji histone demethylases as emerging therapeutic targets.
Park SY; Park JW; Chun YS
Pharmacol Res; 2016 Mar; 105():146-51. PubMed ID: 26816087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
